NASDAQ:SNES - SenesTech Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.52 +0.01 (+0.66 %) (As of 04/26/2019 09:41 AM ET)Previous Close$1.51Today's Range$1.48 - $1.5252-Week Range$0.30 - $2.37Volume10,849 shsAverage Volume286,686 shsMarket Capitalization$35.81 millionP/E RatioN/ADividend YieldN/ABeta1.37 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is headquartered in Flagstaff, Arizona. Receive SNES News and Ratings via Email Sign-up to receive the latest news and ratings for SNES and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SNES Previous Symbol CUSIPN/A CIK1680378 Websenestech.com Phone928-779-4143Debt Debt-to-Equity Ratio0.04 Current Ratio5.74 Quick Ratio4.65Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$300,000.00 Price / Sales119.38 Cash FlowN/A Price / Cash FlowN/A Book Value$0.27 per share Price / Book5.63Profitability EPS (Most Recent Fiscal Year)($0.63) Net Income$-11,910,000.00 Net Margins-4,009.43% Return on Equity-182.12% Return on Assets-148.65%Miscellaneous Employees40 Outstanding Shares23,561,000Market Cap$35.81 million Next Earnings Date5/13/2019 (Estimated) OptionableNot Optionable SenesTech (NASDAQ:SNES) Frequently Asked Questions What is SenesTech's stock symbol? SenesTech trades on the NASDAQ under the ticker symbol "SNES." How were SenesTech's earnings last quarter? SenesTech Inc (NASDAQ:SNES) issued its quarterly earnings data on Thursday, March, 28th. The company reported ($0.10) EPS for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.10). The business earned $0.14 million during the quarter, compared to the consensus estimate of $0.58 million. SenesTech had a negative net margin of 4,009.43% and a negative return on equity of 182.12%. View SenesTech's Earnings History. When is SenesTech's next earnings date? SenesTech is scheduled to release their next quarterly earnings announcement on Monday, May 13th 2019. View Earnings Estimates for SenesTech. Has SenesTech been receiving favorable news coverage? Media headlines about SNES stock have trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. SenesTech earned a news impact score of 1.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the next several days. Are investors shorting SenesTech? SenesTech saw a increase in short interest during the month of March. As of March 15th, there was short interest totalling 1,773,524 shares, an increase of 54.6% from the February 28th total of 1,147,239 shares. Based on an average daily volume of 515,292 shares, the days-to-cover ratio is presently 3.4 days. Currently, 8.3% of the shares of the stock are short sold. View SenesTech's Current Options Chain. Who are some of SenesTech's key competitors? Some companies that are related to SenesTech include Wynnstay Group (WYN), Evogene (EVGN), Arcadia Biosciences (RKDA), Eden Research (EDEN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT), Monsanto (MON), Syngenta (SYT) and Terra Nitrogen (TNH). What other stocks do shareholders of SenesTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), McDermott International (MDR), Marathon Oil (MRO), Adamis Pharmaceuticals (ADMP), Catabasis Pharmaceuticals (CATB), Citius Pharmaceuticals (CTXR), Auris Medical (EARS), ZIOPHARM Oncology (ZIOP) and Allena Pharmaceuticals (ALNA). Who are SenesTech's key executives? SenesTech's management team includes the folowing people: Dr. Loretta Powers Mayer, Co-Founder, Chair of the Board, CEO & Chief Scientific Officer (Age 70)Dr. Cheryl Ann Dyer, Co-Founder, Pres & Chief Research Officer (Age 67)Mr. Thomas C. Chesterman, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 60)Ms. Kim Wolin, Exec. VP of Operations & Sec. (Age 64)Mr. Joe Malinowski, VP of Sales When did SenesTech IPO? (SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager. Who are SenesTech's major shareholders? SenesTech's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.24%). Company insiders that own SenesTech stock include Andrew Altman, Cheryl Ann Dyer, Grover T Wickersham, Julia Ann Williams, Loretta Powers Mayer and Thomas C Chesterman. View Institutional Ownership Trends for SenesTech. Which institutional investors are buying SenesTech stock? SNES stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Company insiders that have bought SenesTech stock in the last two years include Andrew Altman, Grover T Wickersham and Julia Ann Williams. View Insider Buying and Selling for SenesTech. How do I buy shares of SenesTech? Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is SenesTech's stock price today? One share of SNES stock can currently be purchased for approximately $1.52. How big of a company is SenesTech? SenesTech has a market capitalization of $35.81 million and generates $300,000.00 in revenue each year. The company earns $-11,910,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis. SenesTech employs 40 workers across the globe. What is SenesTech's official website? The official website for SenesTech is http://senestech.com. How can I contact SenesTech? SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected] MarketBeat Community Rating for SenesTech (NASDAQ SNES)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 255 (Vote Outperform)Underperform Votes: 268 (Vote Underperform)Total Votes: 523MarketBeat's community ratings are surveys of what our community members think about SenesTech and other stocks. Vote "Outperform" if you believe SNES will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNES will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/26/2019 by MarketBeat.com StaffFeatured Article: What is a growth and income fund?